Skip to content
Open access

MRI-derived oxygen extraction fraction is associated with cognitive impairment in cerebral small vessel disease.

Aug 2026 · International Journal of Stroke · pp. 17474930261485653 · 0 citations
Medicine

TL;DR

MRI-derived OEF was associated with cognitive impairment in CSVD independently of conventional structural MRI burden, and it is suggested that OEF may provide complementary physiological information for characterising cognitive vulnerability in CSVD.

Abstract

Background

Conventional MRI markers of cerebral small vessel disease (CSVD) capture accumulated structural injury but may not fully reflect ongoing physiological dysfunction associated with cognitive impairment.

Aims

We investigated whether MRI-derived oxygen extraction fraction (OEF), a non-invasive marker of cerebral oxygen extraction, is associated with cognitive impairment in CSVD beyond conventional structural MRI burden.

Methods

In this hospital-based observational study, 448 adults with CSVD underwent 3T multiecho gradient-echo MRI for whole-brain OEF mapping using a quantitative susceptibility mapping/quantitative blood oxygen level-dependent framework. Participants were classified as having mild cognitive impairment (MCI) or no MCI by a blinded clinical consensus panel. Whole-brain voxelwise analyses compared OEF between groups and examined associations with the composite cognitive score, Fazekas score, and total CSVD score; post hoc ROI-based analyses examined associations with conventional CSVD burden markers and a composite cognitive score. In an exploratory longitudinal subset of 82 participants, we assessed whether baseline OEF or within-subject OEF change was associated with cognitive change.

Results

Participants with CSVD-MCI showed higher OEF in distributed cortical-subcortical regions than cognitively preserved participants after adjustment for demographic, vascular, and conventional CSVD burden variables. The largest cross-sectional cluster showed higher OEF in the CSVD-MCI group than in the CSVD-no-MCI group (0.342±0.045 vs. 0.294±0.027). Complementary whole-brain analyses and post hoc analyses of the largest group-difference cluster showed that higher OEF was associated with lower composite cognitive scores after covariate adjustment, whereas no associations with Fazekas score or total CSVD score were identified. In the longitudinal subset, baseline OEF was not associated with follow-up composite cognitive score or cognitive change, whereas greater within-subject OEF increase was associated with greater cognitive decline (standardised β=-0.229, p=0.030).

Conclusions

MRI-derived OEF was associated with cognitive impairment in CSVD independently of conventional structural MRI burden. These findings suggest that OEF may provide complementary physiological information for characterising cognitive vulnerability in CSVD. Larger multicentre longitudinal studies incorporating quantitative perfusion imaging and validated amyloid and tau biomarkers are warranted.

Read PDF

Similar papers

Open access Aug 2026

Combined Cerebral Blood Flow and Cerebrovascular Reactivity MRI for Multivariate Classification of Clinically Defined Mild Cognitive Impairment.

BACKGROUND Cerebrovascular dysfunction contributes to mild cognitive impairment (MCI), but the complementary value of arterial spin labeling (ASL)-derived cerebral blood flow (CBF) and breath-hold cerebrovascular reactivity (CVR) for multivariate MRI classification remains unclear. PURPOSE/HYPOTHESIS To determine whe...

Alexander D. Cohen, L. Umfleet, Shawn Obarski et al. · 1 citation
Open access Aug 2026

Biomarker-based assessment of cerebral small vessel disease progression after ischemic stroke – a prospective cohort study (MA-BIO)

Cerebral small vessel disease (CSVD) is a leading cause of ischemic stroke and vascular cognitive impairment, yet currently lacks clinically established biomarkers for monitoring disease activity. While clinical routine magnetic resonance imaging (MRI) can provide quantitative measures of structural brain changes, it d...

L. Hasanova, P. Klassen, A. Nosanova et al. · 0 citations
Open access Sep 2026

Oxygen extraction fraction mapping between normal cognition and mild cognitive impairment in older adults using quantitative BOLD

Abstract Oxygen extraction fraction (OEF) represents the proportion of oxygen utilized by the brain from the blood and is a sensitive biomarker in understanding the vascular interplay between oxygen supply and demand. Alterations in OEF are increasingly recognized in normal aging and the pathophysiology of many neurolo...

Linh N. N. Le, Gregory J. Wheeler, Nicholas P. Blockley et al. · 0 citations
Open access Aug 2026

Left Ventricular Myocardial Strain Impairment Correlates With Cerebral Small Vessel Disease Burden In Patients With Normal Ejection Fraction.

BACKGROUND The relationship between subclinical alterations in heart and brain structure and function remains poorly understood. Emerging evidence indicates that subclinical myocardial dysfunction may be associated with neuroimaging markers of cerebral microvascular injury. PURPOSE To evaluate the association between...

Wanbing Wang, Xinghua Zhang, Meiling Liang et al. · 0 citations
Review Aug 2026

Arterial spin labeling-derived cerebral blood flow as a translational biomarker and candidate surrogate endpoint for cognitive impairment.

PURPOSE OF REVIEW Arterial spin labeling (ASL) MRI noninvasively quantifies cerebral blood flow (CBF), but its role as a mechanistic biomarker and surrogate endpoint in trials of cognitive impairment remains undefined. This review evaluates evidence linking regional CBF to cognition across Alzheimer's disease, mild cog...

Satoshi Hosoki, P. Sachdev, M. Ihara · 0 citations
#small language model Open access Sep 2026

Cerebral microbleeds on susceptibility-weighted imaging, cognitive domains, and serum neurofilament light chain in adults with hypertension

In adults with primary hypertension, greater CMB burden was associated with MCI and selected cognitive domains, whereas cognitive performance did not differ according to CMB location, and prospective validation is required before clinical application.

Zi-Yin Li, Xiao-Bin Zhao, Dan-Dan Zhou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.